Replies to post #341287 on NorthWest Biotherapeutics Inc (NWBO)

[marzan]

I did a conservation 5000 patients per year treating with DcVaxL from Europe alone out of a possible 20000 nGBM patients from Europe alone. 5000x200k brings in a 1B revenue easily which equates to a market cap of 8B if you assign a 8 multiples of the revenue. See NVCR has about 300M revenue and it's MC is a whopping 17B which is about a 60 multiple.